{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:13:35Z","timestamp":1788362015614,"version":"build-2803163510"},"reference-count":201,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T00:00:00Z","timestamp":1582848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI15\/00820"],"award-info":[{"award-number":["PI15\/00820"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/00202"],"award-info":[{"award-number":["PI18\/00202"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005004","name":"Ekonomiaren Garapen eta Lehiakortasun Saila, Eusko Jaurlaritza","doi-asserted-by":"publisher","award":["kk-2018\/00031\/BC"],"award-info":[{"award-number":["kk-2018\/00031\/BC"]}],"id":[{"id":"10.13039\/501100005004","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005004","name":"Ekonomiaren Garapen eta Lehiakortasun Saila, Eusko Jaurlaritza","doi-asserted-by":"publisher","award":["kk-2019\/00093\/BC"],"award-info":[{"award-number":["kk-2019\/00093\/BC"]}],"id":[{"id":"10.13039\/501100005004","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Osteoporosis, the most common chronic metabolic bone disease, is characterized by low bone mass and increased bone fragility. Nowadays more than 200 million individuals are suffering from osteoporosis and still the number of affected people is dramatically increasing due to an aging population and longer life, representing a major public health problem. Current osteoporosis treatments are mainly designed to decrease bone resorption, presenting serious adverse effects that limit their safety for long-term use. Numerous studies with mesenchymal stem cells (MSCs) have helped to increase the knowledge regarding the mechanisms that underlie the progression of osteoporosis. Emerging clinical and molecular evidence suggests that inflammation exerts a significant influence on bone turnover, thereby on osteoporosis. In this regard, MSCs have proven to possess broad immunoregulatory capabilities, modulating both adaptive and innate immunity. Here, we will discuss the role that MSCs play in the etiopathology of osteoporosis and their potential use for the treatment of this disease.<\/jats:p>","DOI":"10.3390\/ijms21051653","type":"journal-article","created":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T03:13:28Z","timestamp":1583205208000},"page":"1653","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["Osteoporosis and the Potential of Cell-Based Therapeutic Strategies"],"prefix":"10.3390","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4900-9949","authenticated-orcid":false,"given":"Iratxe","family":"Mac\u00edas","sequence":"first","affiliation":[{"name":"Stem Cells and Cell Therapy Laboratory, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, Plaza de Cruces S\/N, 48903 Barakaldo, Bizkaia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6087-5288","authenticated-orcid":false,"given":"Natividad","family":"Alcorta-Sevillano","sequence":"additional","affiliation":[{"name":"Stem Cells and Cell Therapy Laboratory, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, Plaza de Cruces S\/N, 48903 Barakaldo, Bizkaia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6749-6288","authenticated-orcid":false,"given":"Clara I.","family":"Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Stem Cells and Cell Therapy Laboratory, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, Plaza de Cruces S\/N, 48903 Barakaldo, Bizkaia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1625-2865","authenticated-orcid":false,"given":"Arantza","family":"Infante","sequence":"additional","affiliation":[{"name":"Stem Cells and Cell Therapy Laboratory, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, Plaza de Cruces S\/N, 48903 Barakaldo, Bizkaia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,2,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/gerona\/glt093","article-title":"Public health impact of osteoporosis","volume":"68","author":"Cauley","year":"2013","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11657-013-0137-0","article-title":"Osteoporosis in the European Union: A compendium of country-specific reports","volume":"8","author":"Svedbom","year":"2013","journal-title":"Arch. Osteoporos."},{"key":"ref_3","first-page":"115","article-title":"Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis","volume":"21","author":"Manolagas","year":"2000","journal-title":"Endocr. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1136\/jcp.2010.077842","article-title":"The pathogenesis, diagnosis, investigation and management of osteoporosis","volume":"64","author":"Sandhu","year":"2011","journal-title":"J. Clin. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00198-005-2039-5","article-title":"Review: Developmental origins of osteoporotic fracture","volume":"17","author":"Cooper","year":"2006","journal-title":"Osteoporos. Int."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/BF01880413","article-title":"The contribution of bone loss to postmenopausal osteoporosis","volume":"1","author":"Hui","year":"1990","journal-title":"Osteoporos. Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jocd.2014.08.001","article-title":"Peak Bone Mass and Patterns of Change in Total Bone Mineral Density and Bone Mineral Contents from Childhood into Young Adulthood","volume":"19","author":"Lu","year":"2016","journal-title":"J. Clin. Densitometry"},{"key":"ref_8","first-page":"333","article-title":"Molecular basis and clinical application of biological markers of bone turnover","volume":"17","author":"Calvo","year":"1996","journal-title":"Endocr. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00198-008-0660-9","article-title":"Biochemical markers of bone turnover: Potential use in the investigation and management of postmenopausal osteoporosis","volume":"19","author":"Szulc","year":"2008","journal-title":"Osteoporos. Int."},{"key":"ref_10","unstructured":"Bauer, D.C. (2001). Biochemical markers of bone turnover: The Study of Osteoporotic Fracture. Bone Markers\u2014Biochemical and Clinical Perspectives, Martin Dunitz."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/PL00004174","article-title":"Predictors of fractures in elderly women","volume":"11","author":"Tromp","year":"2000","journal-title":"Osteoporos. Int."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/jbmr.5650101127","article-title":"Assessment of biochemical markers of bone metabolism in relation to the occurrence of fracture: A retrospective and prospective population-based study of women","volume":"10","author":"Akesson","year":"1995","journal-title":"J. Bone Miner. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/jbmr.5650111021","article-title":"Markers of bone resorption predict hip fracture in elderly women: The EPIDOS Prospective Study","volume":"11","author":"Garnero","year":"1996","journal-title":"J. Bone Miner. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1359\/JBMR.0301244","article-title":"Biochemical markers of bone metabolism and prediction of fracture in elderly women","volume":"19","author":"Gerdhem","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1359\/JBMR.050609","article-title":"Identification of osteopenic women at high risk of fracture: The OFELY study","volume":"20","author":"Munoz","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10867-008-9115-y","article-title":"Bone architecture: Collagen structure and calcium\/phosphorus maps","volume":"34","author":"Tzaphlidou","year":"2008","journal-title":"J. Biol. Phys."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1373\/clinchem.2016.259085","article-title":"Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease","volume":"63","author":"Greenblatt","year":"2017","journal-title":"Clin. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1359\/jbmr.2003.18.5.859","article-title":"The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation","volume":"18","author":"Garnero","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00776-007-1113-6","article-title":"Change of cross-linked telopeptide of type I collagen (ICTP) and other bone resorption markers in patients with bone fragility fractures","volume":"12","author":"Takahara","year":"2007","journal-title":"J. Orthop. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","article-title":"Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: A need for international reference standards","volume":"22","author":"Vasikaran","year":"2011","journal-title":"Osteoporos. Int."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1742-1241.2008.01911.x","article-title":"Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: A consensus document of the Belgian Bone Club","volume":"63","author":"Bergmann","year":"2009","journal-title":"Int. J. Clin. Pract."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S8756-3282(02)00791-3","article-title":"Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): Effects of gender, age, menopausal status, posture, daylight, serum cortisol and fasting","volume":"31","author":"Qvist","year":"2002","journal-title":"Bone"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"846","DOI":"10.4103\/2230-8210.192914","article-title":"Bone turnover markers: Emerging tool in the management of osteoporosis","volume":"20","author":"Shetty","year":"2016","journal-title":"Indian J. Endocrinol. Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1620\/tjem.214.51","article-title":"Higher efficacy of urinary bone resorption marker measurements in assessing response to treatment for osteoporosis in postmenopausal women","volume":"214","author":"Abe","year":"2008","journal-title":"Tohoku J. Exp. Med."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Adler, R.A. (2010). Osteoporosis: Pathophysiology and Clinical Management, Humana. [2nd ed.].","DOI":"10.1007\/978-1-59745-459-9"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Trull, A.K. (2002). Biomarkers of Disease: An Evidence-Based Approach, Cambridge University Press.","DOI":"10.1017\/CBO9780511545962"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1373\/clinchem.2008.105262","article-title":"Automated HPLC assay for urinary collagen cross-links: Effect of age, menopause and metabolic bone diseases","volume":"54","author":"Kraenzlin","year":"2008","journal-title":"Clin. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/jbmr.5650080515","article-title":"Immunoassay for urinary pyridinoline: The new marker of bone resorption","volume":"8","author":"Seyedin","year":"1993","journal-title":"J. Bone Miner. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s001980050170","article-title":"Effects of age, menopause and osteoporosis on free, peptide-bound and total pyridinium crosslink excretion","volume":"9","author":"Aguado","year":"1999","journal-title":"Osteoporos. Int."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clinms.2016.08.001","article-title":"LC\u2013MS\/MS application for urine free pyridinoline and free deoxypyridinoline: Urine markers of collagen and bone degradation","volume":"1","author":"Tang","year":"2016","journal-title":"Clin. Mass Spectrom."},{"key":"ref_31","first-page":"97","article-title":"Biochemical markers of bone turnover: Part I: Biochemistry and variability","volume":"26","author":"Seibel","year":"2005","journal-title":"Clin. Biochem. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0026-0495(85)90145-3","article-title":"Hydroxyproline metabolism by the rat kidney: Distribution of renal enzymes of hydroxyproline catabolism and renal conversion of hydroxyproline to glycine and serine","volume":"34","author":"Lowry","year":"1985","journal-title":"Metabolism"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1248\/bpb.19.163","article-title":"Determination of total hydroxyproline and proline in human serum and urine by HPLC with fluorescence detection","volume":"19","author":"Inoue","year":"1996","journal-title":"Biol. Pharm. Bull."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/B978-0-12-363705-5.50008-7","article-title":"Urinary excretion of hydroxyproline in health and disease","volume":"5","author":"Kivirikko","year":"1970","journal-title":"Int. Rev. Connect. Tissue Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1172\/JCI108704","article-title":"Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation","volume":"59","author":"Krane","year":"1977","journal-title":"J. Clin. Investig."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1042\/cs0590215","article-title":"Collagen and disorders of bone","volume":"59","author":"Smith","year":"1980","journal-title":"Clin. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJM197907053010104","article-title":"The biosynthesis of collagen and its disorders (first of two parts)","volume":"301","author":"Prockop","year":"1979","journal-title":"N. Engl. J. Med."},{"key":"ref_38","unstructured":"Robins, S. (1980). Turnover of Collagen and Its Precursors, Academic Press."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s001980070002","article-title":"The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation","volume":"11","author":"Delmas","year":"2000","journal-title":"Osteoporos. Int."},{"key":"ref_40","unstructured":"Burtis, C.A., Ashwood, E.R., and Bruns, D.E. (2006). Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, Elsevier Saunders. [4th ed.]."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Kraenzlin, M.E., and Seibel, M.J. (2006). Measurement of biochemical markers of bone resorption. Dynamics of Bone and Cartilage Metabolism, Elsevier.","DOI":"10.1016\/B9-78-012088-5\/62650-0340"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1039\/an9840901621","article-title":"High-performance liquid chromatographic analysis of urinary hydroxylysyl glycosides as indicators of collagen turnover","volume":"109","author":"Moro","year":"1984","journal-title":"Analyst"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0022-1759(98)00159-8","article-title":"Development of an immunoassay for urinary galactosylhydroxylysine","volume":"220","author":"Leigh","year":"1998","journal-title":"J. Immunol. Methods"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1016\/S0021-9258(18)96001-1","article-title":"The isolation of identical hydroxylysyl glycosides from hydrolysates of soluble collagen and from human urine","volume":"242","author":"Cunningham","year":"1967","journal-title":"J. Biol. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/clinchem\/38.11.2313","article-title":"Bone-resorption markers galactosyl hydroxylysine, pyridinium crosslinks and hydroxyproline compared","volume":"38","author":"Bettica","year":"1992","journal-title":"Clin. Chem."},{"key":"ref_46","first-page":"271","article-title":"Determination of galactosyl hydroxylysine in urine as a means for the identification of osteoporotic women","volume":"3","author":"Moro","year":"1988","journal-title":"Bone Miner."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02411252","article-title":"Bone acid phosphatase: Tartrate-Resistant acid phosphatase as a marker of osteoclast function","volume":"34","author":"Minkin","year":"1982","journal-title":"Calcif. Tissue Int."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1359\/jbmr.1999.14.3.464","article-title":"Two-site immunoassays for osteoclastic tartrate-resistant acid phosphatase based on characterization of six monoclonal antibodies","volume":"14","author":"Halleen","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1359\/jbmr.2000.15.7.1337","article-title":"Tartrate-resistant acid phosphatase 5b: A novel serum marker of bone resorption","volume":"15","author":"Halleen","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.bone.2003.04.002","article-title":"Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption","volume":"34","author":"Hannon","year":"2004","journal-title":"Bone"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2147\/CIA.S170111","article-title":"Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis","volume":"13","author":"Mederle","year":"2018","journal-title":"Clin. Interv. Aging"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1620\/tjem.224.105","article-title":"Suitability of tartrate-resistant acid phosphatase type 5b as a screening marker for bone mineral density in community-dwelling elderly individuals","volume":"224","author":"Irie","year":"2011","journal-title":"Tohoku J. Exp. Med."},{"key":"ref_53","first-page":"499","article-title":"Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption","volume":"52","author":"Halleen","year":"2006","journal-title":"Clin. Lab."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.critrevonc.2013.08.013","article-title":"Bone sialoprotein and osteopontin in bone metastasis of osteotropic cancers","volume":"89","author":"Kruger","year":"2014","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jbmr.5650100204","article-title":"Biosynthesis of bone sialoprotein by a human osteoclast-like cell line (FLG 29.1)","volume":"10","author":"Masi","year":"1995","journal-title":"J. Bone Miner. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/03008200390152061","article-title":"Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins","volume":"44","author":"Fisher","year":"2003","journal-title":"Connect. Tissue Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/s41598-018-38352-2","article-title":"Elevated serum levels of bone sialoprotein (BSP) predict long-term mortality in patients with pancreatic adenocarcinoma","volume":"9","author":"Loosen","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_58","first-page":"619","article-title":"Serum levels of immunoreactive bone sialoprotein in osteoporosis: Positive relations to established biochemical parameters of bone turnover","volume":"14","author":"Fassbender","year":"2000","journal-title":"In Vivo"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/003655101753218274","article-title":"Serum bone sialoprotein: A marker of bone resorption in postmenopausal osteoporosis","volume":"61","author":"Shaarawy","year":"2001","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1515\/bchm3.1995.376.6.379","article-title":"Human cathepsin O2, a novel cysteine protease highly expressed in osteoclastomas and ovary molecular cloning, sequencing and tissue distribution","volume":"376","author":"Okamoto","year":"1995","journal-title":"Biol. Chem. Hoppe Seyler"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1042\/bj3310727","article-title":"Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix","volume":"331","author":"Kafienah","year":"1998","journal-title":"Biochem. J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/jmicro\/52.6.551","article-title":"Cathepsins in the osteoclast","volume":"52","author":"Goto","year":"2003","journal-title":"J. Electron Microsc."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1210\/endo.142.12.8533","article-title":"Estrogen reduces the depth of resorption pits by disturbing the organic bone matrix degradation activity of mature osteoclasts","volume":"142","author":"Parikka","year":"2001","journal-title":"Endocrinology"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.lfs.2006.12.037","article-title":"Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells","volume":"80","author":"Fujisaki","year":"2007","journal-title":"Life Sci."},{"key":"ref_65","first-page":"1","article-title":"Serum cathepsin K concentrations reflect osteoclastic activity in women with postmenopausal osteoporosis and patients with Paget\u2019s disease","volume":"52","author":"Meier","year":"2006","journal-title":"Clin. Lab."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bcp.2018.02.019","article-title":"4-Phenylbutyric acid protects against lipopolysaccharide-induced bone loss by modulating autophagy in osteoclasts","volume":"151","author":"Park","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1006\/cbir.1994.1088","article-title":"Why does bone matrix contain non-collagenous proteins? The possible roles of osteocalcin, osteonectin, osteopontin and bone sialoprotein in bone mineralisation and resorption","volume":"18","author":"Roach","year":"1994","journal-title":"Cell Biol. Int."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/jcp.24278","article-title":"Osteocalcin: Skeletal and extra-skeletal effects","volume":"228","author":"Neve","year":"2013","journal-title":"J. Cell Physiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1753-4887.1996.tb03798.x","article-title":"Function of the bone protein osteocalcin: Definitive evidence","volume":"54","author":"Wolf","year":"1996","journal-title":"Nutr. Rev."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/382448a0","article-title":"Increased bone formation in osteocalcin-deficient mice","volume":"382","author":"Ducy","year":"1996","journal-title":"Nature"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Tsao, Y.T., Huang, Y.J., Wu, H.H., Liu, Y.A., Liu, Y.S., and Lee, O.K. (2017). Osteocalcin Mediates Biomineralization during Osteogenic Maturation in Human Mesenchymal Stromal Cells. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18010159"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/8756-3282(85)90326-6","article-title":"Serum bone Gla-protein compared to bone histomorphometry in endocrine diseases","volume":"6","author":"Delmas","year":"1985","journal-title":"Bone"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40364-017-0097-4","article-title":"Bone biomarker for the clinical assessment of osteoporosis: Recent developments and future perspectives","volume":"5","author":"Kuo","year":"2017","journal-title":"Biomark. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/clinchem\/40.11.2071","article-title":"Six osteocalcin assays compared","volume":"40","author":"Guerrero","year":"1994","journal-title":"Clin. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/clinchem\/46.3.332","article-title":"Development and evaluation of three immunofluorometric assays that measure different forms of osteocalcin in serum","volume":"46","author":"Hellman","year":"2000","journal-title":"Clin. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Eick, G.N., Madimenos, F.C., Cepon-Robins, T.J., Devlin, M.J., Kowal, P., Sugiyama, L.S., and Snodgrass, J.J. (2020). Validation of an enzyme-linked immunoassay assay for osteocalcin, a marker of bone formation, in dried blood spots. Am. J. Hum. Biol., e23394.","DOI":"10.1002\/ajhb.23394"},{"key":"ref_77","first-page":"3","article-title":"Present status and future trends of human alkaline phosphatases","volume":"166","author":"Stigbrand","year":"1984","journal-title":"Prog. Clin. Biol. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1359\/jbmr.1999.14.11.1926","article-title":"Isoforms of bone alkaline phosphatase: Characterization and origin in human trabecular and cortical bone","volume":"14","author":"Magnusson","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0009-8981(90)90031-M","article-title":"The human alkaline phosphatases: What we know and what we don\u2019t know","volume":"186","author":"Harris","year":"1990","journal-title":"Clin. Chim. Acta"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/0004563213515190","article-title":"Biochemical markers of bone turnover-uses and limitations","volume":"51","author":"Hlaing","year":"2014","journal-title":"Ann. Clin. Biochem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/clinchem\/41.11.1560","article-title":"Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum","volume":"41","author":"Gomez","year":"1995","journal-title":"Clin. Chem."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Orwoll, E.S., and Bliziotes, M. (2003). Osteoporosis: Pathophysiology and Clinical Management, Humana Press.","DOI":"10.1385\/1592592783"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.clinbiochem.2012.03.023","article-title":"Measurement of aminoterminal propeptide of type I procollagen (PINP) in serum","volume":"45","author":"Koivula","year":"2012","journal-title":"Clin. Biochem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1084\/jem.179.2.405","article-title":"Clearance of NH2-terminal propeptides of types I and III procollagen is a physiological function of the scavenger receptor in liver endothelial cells","volume":"179","author":"Melkko","year":"1994","journal-title":"J. Exp. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1007\/s00198-014-2646-0","article-title":"PINP as a biological response marker during teriparatide treatment for osteoporosis","volume":"25","author":"Krege","year":"2014","journal-title":"Osteoporos. Int."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0168-8278(89)90048-2","article-title":"Hepatic and renal extraction of circulating type III procollagen amino-terminal propeptide and hyaluronan in pig","volume":"9","author":"Bentsen","year":"1989","journal-title":"J. Hepatol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1359\/JBMR.050105","article-title":"Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis","volume":"20","author":"Chen","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"ref_88","first-page":"237","article-title":"Harmonised Australian Reference Intervals for Serum PINP and CTX in Adults","volume":"35","author":"Vasikaran","year":"2014","journal-title":"Clin. Biochem. Rev."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1042\/bj2710345","article-title":"Circulating C-terminal propeptide of type I procollagen is cleared mainly via the mannose receptor in liver endothelial cells","volume":"271","author":"Melkko","year":"1990","journal-title":"Biochem. J."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1515\/CCLM.2011.602","article-title":"International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis","volume":"49","author":"Vasikaran","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1007\/s00198-012-2049-z","article-title":"National Bone Health Alliance Bone Turnover Marker Project: Current practices and the need for US harmonization, standardization and common reference ranges","volume":"23","author":"Bauer","year":"2012","journal-title":"Osteoporos. Int."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1177\/0269215509339002","article-title":"Effects of exercise programmes on quality of life in osteoporotic and osteopenic postmenopausal women: A systematic review and meta-analysis","volume":"23","author":"Li","year":"2009","journal-title":"Clin. Rehabil."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Lambert, C., Beck, B.R., Watson, S.L., Harding, A.T., and Weeks, B.K. (2020). Enjoyment and acceptability of different exercise modalities to improve bone health in young adult women. Health Promot. J. Aust.","DOI":"10.1002\/hpja.321"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Bragonzoni, L., Barone, G., Benvenuti, F., Canal, V., Ripamonti, C., Marini, S., and Dallolio, L. (2020). A Randomized Clinical Trial to Evaluate the Efficacy and Safety of the ACTLIFE Exercise Program for Women with Post-menopausal Osteoporosis: Study Protocol. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17030809"},{"key":"ref_95","first-page":"9758289","article-title":"Effects of 12-Week Exercise Program on Enzyme Activity of Serum Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Female Patients with Postmenopausal Osteoporosis: A Randomized Control Study","volume":"2020","year":"2020","journal-title":"BioMed Res. Int."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e10246","DOI":"10.1002\/jbm4.10246","article-title":"Calcium Supplement Use Is Associated With Less Bone Mineral Density Loss but Does Not Lessen the Risk of Bone Fracture Across the Menopause Transition: Data From the Study of Women\u2019s Health Across the Nation","volume":"4","author":"Bailey","year":"2020","journal-title":"JBMR Plus"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00198-015-3386-5","article-title":"Calcium plus vitamin D supplementation and risk of fractures: An updated meta-analysis from the National Osteoporosis Foundation","volume":"27","author":"Weaver","year":"2016","journal-title":"Osteoporos. Int."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1359\/jbmr.1998.13.5.763","article-title":"A unitary model for involutional osteoporosis: Estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men","volume":"13","author":"Riggs","year":"1998","journal-title":"J. Bone Miner. Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1248\/bpb.24.351","article-title":"Interaction of phytoestrogens with estrogen receptors \u03b1 and \u03b2","volume":"24","author":"Morito","year":"2001","journal-title":"Biol. Pharm. Bull."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3945\/ajcn.117.153353","article-title":"Combined bioavailable isoflavones and probiotics improve bone status and estrogen metabolism in postmenopausal osteopenic women: A randomized controlled trial","volume":"106","author":"Lambert","year":"2017","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.bone.2008.12.020","article-title":"Effect of long-term intervention of soy isoflavones on bone mineral density in women: A meta-analysis of randomized controlled trials","volume":"44","author":"Liu","year":"2009","journal-title":"Bone"},{"key":"ref_102","first-page":"1","article-title":"Osteoporosis: Current and emerging therapies targeted to immunological checkpoints","volume":"26","author":"Sirufo","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev-med-052218-020620","article-title":"New Frontiers in Osteoporosis Therapy","volume":"71","author":"Cheng","year":"2019","journal-title":"Annu. Rev. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bone.2012.11.011","article-title":"The molecular mechanisms underlying the pharmacological actions of estrogens, SERMs and oxysterols: Implications for the treatment and prevention of osteoporosis","volume":"53","author":"Nelson","year":"2013","journal-title":"Bone"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4184\/asj.2016.10.4.787","article-title":"Selective Estrogen Receptor Modulators","volume":"10","author":"An","year":"2016","journal-title":"Asian Spine J."},{"key":"ref_107","first-page":"1437","article-title":"Selective estrogen receptor modulators: Tissue specificity and clinical utility","volume":"9","author":"Martinkovich","year":"2014","journal-title":"Clin. Interv. Aging"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Stapleton, M., Sawamoto, K., Alm\u00e9ciga-D\u00edaz, C.J., Mackenzie, W.G., Mason, R.W., Orii, T., and Tomatsu, S. (2017). Development of Bone Targeting Drugs. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18071345"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11926-003-0085-6","article-title":"Bisphosphonate mechanism of action","volume":"5","author":"Reszka","year":"2003","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bone.2013.09.023","article-title":"Update on long-term treatment with bisphosphonates for postmenopausal osteoporosis: A systematic review","volume":"58","author":"Eriksen","year":"2014","journal-title":"Bone"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0025-6196(11)60752-0","article-title":"Adverse effects of bisphosphonates: Implications for osteoporosis management","volume":"84","author":"Kennel","year":"2009","journal-title":"Mayo Clin. Proc."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1517\/17425255.2015.1000860","article-title":"Denosumab for the treatment of osteoporosis","volume":"11","author":"Zaheer","year":"2015","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","article-title":"Denosumab and bisphosphonates: Different mechanisms of action and effects","volume":"48","author":"Baron","year":"2011","journal-title":"Bone"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1530\/EJE-18-0056","article-title":"Therapy of endocrine disease: Denosumab vs. bisphosphonates for the treatment of postmenopausal osteoporosis","volume":"179","author":"Anastasilakis","year":"2018","journal-title":"Eur. J. Endocrinol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1210\/er.2004-0006","article-title":"Parathyroid hormone and teriparatide for the treatment of osteoporosis: A review of the evidence and suggested guidelines for its use","volume":"26","author":"Hodsman","year":"2005","journal-title":"Endocr. Rev."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1007\/s00198-016-3534-6","article-title":"Teriparatide for osteoporosis: Importance of the full course","volume":"27","author":"Lindsay","year":"2016","journal-title":"Osteoporos. Int."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/01926230252929882","article-title":"Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1\u201334) for 2 years and relevance to human safety","volume":"30","author":"Vahle","year":"2002","journal-title":"Toxicol. Pathol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/01926230490462138","article-title":"Bone neoplasms in F344 rats given teriparatide [rhPTH(1\u201334)] are dependent on duration of treatment and dose","volume":"32","author":"Vahle","year":"2004","journal-title":"Toxicol. Pathol."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Schemitsch, E.H., Miclau, T., Karachalios, T., Nowak, L.L., Sancheti, P., Poolman, R.W., Caminis, J., Daizadeh, N., Dent-Acosta, R.E., and Egbuna, O. (2020). A Randomized, Placebo-Controlled Study of Romosozumab for the Treatment of Hip Fractures. JBJS.","DOI":"10.2106\/JBJS.19.00790"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1210\/er.2011-1060","article-title":"Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases","volume":"33","author":"Ke","year":"2012","journal-title":"Endocr. Rev."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nrrheum.2011.130","article-title":"New targets for intervention in the treatment of postmenopausal osteoporosis","volume":"7","author":"Lewiecki","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/1759720X13510479","article-title":"Role of sclerostin in bone and cartilage and its potential as a therapeutic target in bone diseases","volume":"6","author":"Lewiecki","year":"2014","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"684736","DOI":"10.1155\/2013\/684736","article-title":"Review of Signaling Pathways Governing MSC Osteogenic and Adipogenic Differentiation","volume":"2013","author":"James","year":"2013","journal-title":"Scientifica"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00198-009-0981-3","article-title":"The role of cigarette smoking and statins in the development of postmenopausal osteoporosis: A pilot study utilizing the Marshfield Clinic Personalized Medicine Cohort","volume":"21","author":"Giampietro","year":"2010","journal-title":"Osteoporos. Int."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-018-0995-x","article-title":"Osteogenesis and aging: Lessons from mesenchymal stem cells","volume":"9","author":"Infante","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/BOR.0b013e3283025e9c","article-title":"Bone and fat connection in aging bone","volume":"20","author":"Duque","year":"2008","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/(SICI)1097-4644(19991201)75:3<414::AID-JCB7>3.0.CO;2-C","article-title":"Abnormal osteogenesis in osteoporotic patients is reflected by altered mesenchymal stem cells dynamics","volume":"75","author":"Garat","year":"1999","journal-title":"J. Cell Biochem."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/1097-4644(20001215)79:4<557::AID-JCB40>3.0.CO;2-H","article-title":"Mesenchymal stem cells from osteoporotic patients produce a type I collagen-deficient extracellular matrix favoring adipogenic differentiation","volume":"79","author":"Montecinos","year":"2000","journal-title":"J. Cell Biochem."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/cdd.2015.168","article-title":"Fate decision of mesenchymal stem cells: Adipocytes or osteoblasts?","volume":"23","author":"Chen","year":"2016","journal-title":"Cell Death Differ."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.abb.2008.02.030","article-title":"Transcription factors controlling osteoblastogenesis","volume":"473","author":"Marie","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.4252\/wjsc.v11.i12.1084","article-title":"Small molecules for mesenchymal stem cell fate determination","volume":"11","author":"Cheng","year":"2019","journal-title":"World J. Stem Cells"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.diff.2016.02.005","article-title":"Key transcription factors in the differentiation of mesenchymal stem cells","volume":"92","author":"Almalki","year":"2016","journal-title":"Differentiation"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Valenti, M.T., Garbin, U., Pasini, A., Zanatta, M., Stranieri, C., Manfro, S., Zucal, C., and Dalle Carbonare, L. (2011). Role of ox-PAPCs in the differentiation of mesenchymal stem cells (MSCs) and Runx2 and PPAR\u03b32 expression in MSCs-like of osteoporotic patients. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0020363"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2174\/1574888X12666171012141908","article-title":"PPAR-\u03b3 and Wnt Regulate the Differentiation of MSCs into Adipocytes and Osteoblasts Respectively","volume":"13","author":"Li","year":"2018","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1749-799X-6-30","article-title":"Effects of obesity on bone metabolism","volume":"6","author":"Cao","year":"2011","journal-title":"J. Orthop. Surg. Res."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-11-0132","article-title":"Osteoblasts in osteoporosis: Past, emerging and future anabolic targets","volume":"165","author":"Marie","year":"2011","journal-title":"Eur. J. Endocrinol."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Benisch, P., Schilling, T., Klein-Hitpass, L., Frey, S.P., Seefried, L., Raaijmakers, N., Krug, M., Regensburger, M., Zeck, S., and Schinke, T. (2012). The transcriptional profile of mesenchymal stem cell populations in primary osteoporosis is distinct and shows overexpression of osteogenic inhibitors. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0045142"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/stem.1118","article-title":"Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation","volume":"30","author":"Batsis","year":"2012","journal-title":"Stem Cells"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1111\/j.1582-4934.2010.01230.x","article-title":"Systemic transplantation of human adipose-derived stem cells stimulates bone repair by promoting osteoblast and osteoclast function","volume":"15","author":"Lee","year":"2011","journal-title":"J. Cell Mol. Med."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Sinder, B.P., Novak, S., Wee, N.K.Y., Basile, M., Maye, P., Matthews, B.G., and Kalajzic, I. (2019). Engraftment of skeletal progenitor cells by bone directed transplantation improves osteogenesis imperfecta murine bone phenotype. Stem Cells, 1\u201312.","DOI":"10.1002\/stem.3133"},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Hu, L., Yin, C., Zhao, F., Ali, A., Ma, J., and Qian, A. (2018). Mesenchymal Stem Cells: Cell Fate Decision to Osteoblast or Adipocyte and Application in Osteoporosis Treatment. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19020360"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1634\/stemcells.20-6-542","article-title":"Prevention of senile osteoporosis in SAMP6 mice by intrabone marrow injection of allogeneic bone marrow cells","volume":"20","author":"Ichioka","year":"2002","journal-title":"Stem Cells"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3109\/03008201003597049","article-title":"Intra-bone marrow injection of mesenchymal stem cells improves the femur bone mass of osteoporotic female rats","volume":"51","author":"Ocarino","year":"2010","journal-title":"Connect. Tissue Res."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.5966\/sctm.2015-0347","article-title":"Allogeneic Mesenchymal Stem Cell Therapy Promotes Osteoblastogenesis and Prevents Glucocorticoid-Induced Osteoporosis","volume":"5","author":"Sui","year":"2016","journal-title":"Stem Cells Transl. Med."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"683","DOI":"10.5966\/sctm.2015-0231","article-title":"Systemic Mesenchymal Stromal Cell Transplantation Prevents Functional Bone Loss in a Mouse Model of Age-Related Osteoporosis","volume":"5","author":"Kiernan","year":"2016","journal-title":"Stem Cells Transl. Med."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1016\/j.biomaterials.2012.03.069","article-title":"The use of autologous enriched bone marrow MSCs to enhance osteoporotic bone defect repair in long-term estrogen deficient goats","volume":"33","author":"Cao","year":"2012","journal-title":"Biomaterials"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.mad.2007.12.002","article-title":"Age-related changes in human bone marrow-derived mesenchymal stem cells: Consequences for cell therapies","volume":"129","author":"Stolzing","year":"2008","journal-title":"Mech. Ageing Dev."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1634\/stemcells.2005-0342","article-title":"Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood or adipose tissue","volume":"24","author":"Kern","year":"2006","journal-title":"Stem Cells"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00441-007-0555-7","article-title":"Effect of tissue-harvesting site on yield of stem cells derived from adipose tissue: Implications for cell-based therapies","volume":"332","author":"Jurgens","year":"2008","journal-title":"Cell Tissue Res."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1479-5876-12-8","article-title":"Donor age negatively impacts adipose tissue-derived mesenchymal stem cell expansion and differentiation","volume":"12","author":"Choudhery","year":"2014","journal-title":"J. Transl. Med."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"7326","DOI":"10.1016\/j.biomaterials.2014.05.016","article-title":"Therapeutic potential of adipose-derived stromal cells in age-related osteoporosis","volume":"35","author":"Mirsaidi","year":"2014","journal-title":"Biomaterials"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1089\/ten.tea.2011.0355","article-title":"Human adipose tissue-derived stromal cell therapy prevents bone loss in ovariectomized nude mouse","volume":"18","author":"Cho","year":"2012","journal-title":"Tissue Eng. Part A"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.jcyt.2014.07.009","article-title":"Adipose-derived stem cells alleviate osteoporosis by enhancing osteogenesis and inhibiting adipogenesis in a rabbit model","volume":"16","author":"Ye","year":"2014","journal-title":"Cytotherapy"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4252\/wjsc.v2.i4.81","article-title":"Mesenchymal stromal cells from human perinatal tissues: From biology to cell therapy","volume":"2","author":"Bieback","year":"2010","journal-title":"World J. Stem Cells"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/bmb\/lds008","article-title":"Umbilical cord blood stem cells: Clinical trials in non-hematological disorders","volume":"102","author":"Ilic","year":"2012","journal-title":"Br. Med. Bull."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1634\/stemcells.2006-0286","article-title":"Biology of stem cells in human umbilical cord stroma: In situ and in vitro surveys","volume":"25","author":"Karahuseyinoglu","year":"2007","journal-title":"Stem Cells"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/jbm.a.32186","article-title":"Human umbilical cord mesenchymal stem cells: Osteogenesis in vivo as seed cells for bone tissue engineering","volume":"91","author":"Diao","year":"2009","journal-title":"J. BioMed Mater. Res. A"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1089\/ten.tea.2012.0047","article-title":"Transplantation of human umbilical cord blood-derived mesenchymal stem cells or their conditioned medium prevents bone loss in ovariectomized nude mice","volume":"19","author":"An","year":"2013","journal-title":"Tissue Eng. Part A"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1073\/pnas.88.12.5134","article-title":"Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells","volume":"88","author":"Pacifici","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11914-012-0104-5","article-title":"Pathways for bone loss in inflammatory disease","volume":"10","author":"Braun","year":"2012","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/jbmr.1559","article-title":"Inflammatory markers and the risk of hip fracture: The Women\u2019s Health Initiative","volume":"27","author":"Barbour","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/nm1096-1132","article-title":"Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta","volume":"2","author":"Hughes","year":"1996","journal-title":"Nat. Med."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s10495-005-0618-8","article-title":"Induction of apoptosis of human primary osteoclasts treated with a transcription factor decoy mimicking a promoter region of estrogen receptor alpha","volume":"10","author":"Piva","year":"2005","journal-title":"Apoptosis"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"8836","DOI":"10.1074\/jbc.M010764200","article-title":"Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation","volume":"276","author":"Srivastava","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nrendo.2013.179","article-title":"The role of estrogen and androgen receptors in bone health and disease","volume":"9","author":"Manolagas","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI200317215","article-title":"Role of RANK ligand in mediating increased bone resorption in early postmenopausal women","volume":"111","author":"Khosla","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bone.2008.02.017","article-title":"Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: A key mechanism in osteoporosis","volume":"43","author":"Grimaldi","year":"2008","journal-title":"Bone"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.2310\/JIM.0000000000000016","article-title":"Bone loss in surgically ovariectomized premenopausal women is associated with T lymphocyte activation and thymic hypertrophy","volume":"61","author":"Adeel","year":"2013","journal-title":"J. Investig. Med."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1172\/JCI117424","article-title":"Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow","volume":"94","author":"Masuzawa","year":"1994","journal-title":"J. Clin. Investig."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.injury.2016.10.008","article-title":"The roles of immune cells in bone healing; what we know, do not know and future perspectives","volume":"47","author":"Jones","year":"2016","journal-title":"Injury"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1302\/0301-620X.90B8.20861","article-title":"Fracture healing in HIV-positive populations","volume":"90","author":"Richardson","year":"2008","journal-title":"J. Bone Jt. Surg. Br."},{"key":"ref_174","first-page":"307","article-title":"Changes in some indices of cellular immunity in patients with uncomplicated and complicated healing of bone fractures","volume":"25","author":"Askalonov","year":"1981","journal-title":"J. Hyg. Epidemiol. Microbiol. Immunol."},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Nam, D., Mau, E., Wang, Y., Wright, D., Silkstone, D., Whetstone, H., Whyne, C., and Alman, B. (2012). T-lymphocytes enable osteoblast maturation via IL-17F during the early phase of fracture repair. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0040044"},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Medhat, D., Rodr\u00edguez, C.I., and Infante, A. (2019). Immunomodulatory Effects of MSCs in Bone Healing. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20215467"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ni.3002","article-title":"Plasticity of mesenchymal stem cells in immunomodulation: Pathological and therapeutic implications","volume":"15","author":"Wang","year":"2014","journal-title":"Nat. Immunol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"732742","DOI":"10.1155\/2013\/732742","article-title":"MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies and Immune Modulation","volume":"2013","author":"Kean","year":"2013","journal-title":"Stem Cells Int."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/stem.2415","article-title":"Cryopreserved Mesenchymal Stromal Cells Are Susceptible to T-Cell Mediated Apoptosis Which Is Partly Rescued by IFN\u03b3 Licensing","volume":"34","author":"Chinnadurai","year":"2016","journal-title":"Stem Cells"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1182\/blood-2005-07-2657","article-title":"Human mesenchymal stem cells modulate B-cell functions","volume":"107","author":"Corcione","year":"2006","journal-title":"Blood"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3324\/haematol.12857","article-title":"The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes","volume":"93","author":"Tabera","year":"2008","journal-title":"Haematologica"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/scd.2014.0155","article-title":"Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells","volume":"24","author":"Rosado","year":"2015","journal-title":"Stem Cells Dev."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1182\/blood-2004-02-0586","article-title":"Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells","volume":"105","author":"Jiang","year":"2005","journal-title":"Blood"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1182\/blood-2004-07-2921","article-title":"Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness","volume":"105","author":"Beyth","year":"2005","journal-title":"Blood"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1182\/blood-2005-11-011650","article-title":"Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting","volume":"108","author":"Nauta","year":"2006","journal-title":"Blood"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1182\/blood-2005-07-2775","article-title":"Mesenchymal stem cell-natural killer cell interactions: Evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation","volume":"107","author":"Spaggiari","year":"2006","journal-title":"Blood"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1038\/s41467-019-10491-8","article-title":"Mesenchymal stem cell therapy induces FLT3L and CD1c","volume":"10","author":"Yuan","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1182\/blood-2007-02-074997","article-title":"Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity and cytokine production: Role of indoleamine 2,3-dioxygenase and prostaglandin E2","volume":"111","author":"Spaggiari","year":"2008","journal-title":"Blood"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"143463","DOI":"10.1155\/2014\/143463","article-title":"Interaction with mesenchymal stem cells provokes natural killer cells for enhanced IL-12\/IL-18-induced interferon-gamma secretion","volume":"2014","author":"Thomas","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1634\/stemcells.2007-0416","article-title":"Human mesenchymal stem cells inhibit neutrophil apoptosis: A model for neutrophil preservation in the bone marrow niche","volume":"26","author":"Raffaghello","year":"2008","journal-title":"Stem Cells"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1189\/jlb.0410207","article-title":"Tissue-resident mesenchymal stem cells attract peripheral blood neutrophils and enhance their inflammatory activity in response to microbial challenge","volume":"88","author":"Brandau","year":"2010","journal-title":"J. Leukoc. Biol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/stem.1270","article-title":"Mesenchymal stromal cells improve survival during sepsis in the absence of heme oxygenase-1: The importance of neutrophils","volume":"31","author":"Hall","year":"2013","journal-title":"Stem Cells"},{"key":"ref_194","first-page":"3890","article-title":"MSC: Immunoregulatory effects, roles on neutrophils and evolving clinical potentials","volume":"11","author":"Joel","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/stem.1400","article-title":"Concise review: Two negative feedback loops place mesenchymal stem\/stromal cells at the center of early regulators of inflammation","volume":"31","author":"Prockop","year":"2013","journal-title":"Stem Cells"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"38308","DOI":"10.1038\/srep38308","article-title":"Human Mesenchymal stem cells program macrophage plasticity by altering their metabolic status via a PGE","volume":"6","author":"Vasandan","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/stem.503","article-title":"Human gingiva-derived mesenchymal stem cells elicit polarization of m2 macrophages and enhance cutaneous wound healing","volume":"28","author":"Zhang","year":"2010","journal-title":"Stem Cells"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1038\/emm.2013.135","article-title":"Mesenchymal stem cells reciprocally regulate the M1\/M2 balance in mouse bone marrow-derived macrophages","volume":"46","author":"Cho","year":"2014","journal-title":"Exp. Mol. Med."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1182\/blood-2010-12-327353","article-title":"Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2\/NF-\u03baB signaling in resident macrophages","volume":"118","author":"Choi","year":"2011","journal-title":"Blood"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.stem.2013.09.006","article-title":"Mesenchymal stromal cells: Sensors and switchers of inflammation","volume":"13","author":"Bernardo","year":"2013","journal-title":"Cell Stem Cell"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2478\/10004-1254-65-2014-2541","article-title":"Low-grade chronic inflammation perpetuated by modern diet as a promoter of obesity and osteoporosis","volume":"65","author":"Ilich","year":"2014","journal-title":"Arch. Hyg. Rada Toksikol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/5\/1653\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:02:39Z","timestamp":1760173359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/5\/1653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,28]]},"references-count":201,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,3]]}},"alternative-id":["ijms21051653"],"URL":"https:\/\/doi.org\/10.3390\/ijms21051653","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,28]]}}}